Diseases of the central nervous system (CNS) and mental health issues represent a major burden on society, and there is considerable room for improvements of the current therapeutic alternatives. Swedish pharma company
Read the full interview with Dr Michael-Robin Witt at biostock.se:
https://www.biostock.se/2021/02/gabather-focus-on-cns-diseases/
This is a press release from BioStock - Connecting Innovation & Capital.
https://news.cision.com/gabather-ab/r/biostock-gabather---focus-on-cns-diseases,c3277890
(c) 2021 Cision. All rights reserved., source